"We specialize in all medical dermatology, including acne, rashes, eczema, psoriasis, rosacea, warts, and any other skin condition."

During the past decade, California Dermatology Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "California Dermatology Institute" are "Psoriasis" (2 trials) and "WHIM Syndrome" (1 trials). Many other conditions were trialed in "California Dermatology Institute" in a lesser frequency.

Most popular intervention types in "California Dermatology Institute" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apremilast" (1 trials), "Apremilast (CC-10004)" (1 trials) and "Mavorixafor" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Dermatology Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "California Dermatology Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in California Dermatology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in California Dermatology Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".